458
Participants
Start Date
May 7, 2018
Primary Completion Date
January 28, 2020
Study Completion Date
March 12, 2021
WATCHMAN FLX
Left atrial appendage closure with WATCHMAN FLX
New York University Medical Center, New York
Mt. Sinai School of Medicine, New York
York Hospital, York
Washington Hospital Center, Washington D.C.
Virginia Commonwealth University Health System, Richmond
Sentara Norfolk General Hospital, Norfolk
Emory University, Atlanta
Tallahassee Memorial Hospital, Tallahassee
Grandview Medical Center, Birmingham
Vanderbilt University Medical Center, Nashville
Cardiology Associates of N. Mississippi, Tupelo
Cleveland Clinic, Cleveland
Henry Ford Hospital, Detroit
HealthEast St. Joseph's Hospital, Saint Paul
Mayo Clinic, Rochester
St. Luke's Hospital, Kansas City
Nair Research, LLC, Jonesboro
Texas Cardiac Arrhythmia, Austin
Phoenix Cardiovascular Research Group, Phoenix
St. Joseph's Hospital & Medical Center, Phoenix
Cedars-Sinai Medical Center, Los Angeles
St. John's Hospital / Pacific Heart, Santa Monica
Scripps Green, La Jolla
Sharpe Chula Vista Medical Center, San Diego
Legacy Emanuel Hospital & Health Center, Portland
PeaceHealth Southwest Medical, Vancouver
Massachusetts General Hospital, Boston
Catholic Medical Center, Manchester
Cardiovascular Associates of the Delaware Valley, Sewell
Lead Sponsor
Boston Scientific Corporation
INDUSTRY